Altered lipoprotein subclass distribution and PAF-AH activity in subjects with generalized aggressive periodontitis

Journal of Lipid Research

Volumn 46, Issue 12, 2005, Pages 2752-2760

  Rufail, Miguel L ^a   Schenkein, Harvey A ^a   Barbour, Suzanne E ^a   Tew, John G ^a   Van Antwerpen, Rik ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Lipoprotein associated phospholipase A2; Low density lipoprotein; Nuclear magnetic resonance; Pattern B lipoprotein profile; Platelet activating factor acetylhydrolase

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; HIGH DENSITY LIPOPROTEIN; INTERMEDIATE DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE; PERIODONTITIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ADULT; CHOLESTEROL; FEMALE; HUMANS; LIPOPROTEINS; MALE; PERIODONTITIS; TRIGLYCERIDES;

EID: 30844456195     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M500389-JLR200     Document Type: Article

References (70)

1. Socransky, S. S., and A. D. Haffajee. 2005. Periodontal microbial ecology. Periodontol. 2000. 38: 135-187.
2. Offenbacher, S. 1996. Periodontal diseases: pathogenesis. Ann. Periodontol. 1: 821-878.
3. Mattila, K. J., M. S. Nieminen, V. V. Valtonen, V. P. Rasi, Y. A. Kesaniemi, S. L. Syrjala, P. S. Jungell, M. Isoluoma, K. Hietaniemi, and M. J. Jokinen. 1989. Association between dental health and acute myocardial infarction. BMJ. 298: 779-781.
4. Syrjanen, J., J. Peltola, V. Valtonen, M. Iivanainen, M. Kaste, and J. K. Huttunen. 1989. Dental infections in association with cerebral infarction in young and middle-aged men. J. Intern. Med. 225: 179-184.
5. DeStefano, F., R. F. Anda, H. S. Kahn, D. F. Williamson, and C. M. Russell. 1993. Dental disease and risk of coronary heart disease and mortality. BMJ. 306: 688-691.
6. Kweider, M., G. D. Lowe, G. D. Murray, D. F. Kinane, and D. A. McGowan. 1993. Dental disease, fibrinogen and white cell count: links with myocardial infarction? Scott. Med. J. 38: 73-74.
7. Mattila, K. J., M. S. Valle, M. S. Nieminen, V. V. Valtonen, and K. L. Hietaniemi. 1993. Dental infections and coronary atherosclerosis. Atherosclerosis. 103: 205-211.
8. Mattila, K. J., V. V. Valtonen, M. Nieminen, and J. K. Huttunen. 1995. Dental infection and the risk of new coronary events: prospective study of patients with documented coronary artery disease. Clin. Infect. Dis. 20: 588-592.
9. Beck, J., R. Garcia, G. Heiss, P. S. Vokonas, and S. Offenbacher. 1996. Periodontal disease and cardiovascular disease. J. Periodontol. 67: 1123-1137.
10. Joshipura, K. J., E. B. Rimm, C. W. Douglass, D. Trichopoulos, A. Ascherio, and W. C. Willett. 1996. Poor oral health and coronary heart disease. J. Dent. Res. 75: 1631-1636.
11. Grau, A. J., F. Buggle, C. Ziegler, W. Schwarz, J. Meuser, A. J. Tasman, A. Buhler, C. Benesch, H. Becher, and W. Hacke. 1997. Association between acute cerebrovascular ischemia and chronic and recurrent infection. Stroke. 28: 1724-1729.
12. Loesche, W. J., A. Schork, M. S. Terpenning, Y. M. Chen, C. Kerr, and B. L. Dominguez. 1998. The relationship between dental disease and cerebral vascular accident in elderly United States veterans. Ann. Periodontol. 3: 161-174.
13. Morrison, H. I., L. F. Ellison, and G. W. Taylor. 1999. Periodontal disease and risk of fatal coronary heart and cerebrovascular diseases. J. Cardiovasc. Risk. 6: 7-11.
14. Joshipura, K. J., H. C. Hung, E. B. Rimm, W. C. Willett, and A. Ascherio. 2003. Periodontal disease, tooth loss, and incidence of ischemic stroke. Stroke. 34: 47-52.
15. Dorfer, C. E., H. Becher, C. M. Ziegler, C. Kaiser, R. Lutz, D. Jorss, C. Lichy, F. Buggle, S. Bultmann, M. Preusch, et al. 2004. The association of gingivitis and periodontitis with ischemic stroke. J. Clin. Periodontol. 31: 396-401.
16. Grau, A. J., H. Becher, C. M. Ziegler, C. Lichy, F. Buggle, C. Kaiser, R. Lutz, S. Bultmann, M. Preusch, and C. E. Dorfer. 2004. Periodontal disease as a risk factor for ischemic stroke. Stroke. 35: 496-501.
17. Amar, S., N. Gokce, S. Morgan, M. Loukideli, T. E. Van Dyke, and J. A. Vita. 2003. Periodontal disease is associated with brachial artery endothelial dysfunction and systemic inflammation. Arterioscler. Thromb. Vasc. Biol. 23: 1245-1249.
18. Beck, J. D., J. R. Elter, G. Heiss, D. Couper, S. M. Mauriello, and S. Offenbacher. 2001. Relationship of periodontal disease to carotid artery intima-media wall thickness: the Atherosclerosis Risk In Communities (ARIC) Study. Arterioscler. Thromb. Vasc. Biol. 21: 1816-1822.
19. Engebretson, S. P., I. B. Lamster, M. S. Elkind, T. Rundek, N. J. Serman, R. T. Demmer, R. L. Sacco, P. N. Papapanou, and M. Desvarieux. 2005. Radiographic measures of chronic periodontitis and carotid artery plaque. Stroke. 36: 561-566.
20. Pussinen, P. J., M. Jauhiainen, T. Vilkuna-Rautiainen, J. Sundvall, M. Vesanen, K. Mattila, T. Palosuo, G. Alfthan, and S. Asikainen. 2004. Periodontitis decreases the antiatherogenic potency of high density lipoprotein. J. Lipid Res. 45: 139-147.
21. Pussinen, P. J., T. Vilkuna-Rautiainen, G. Alfthan, T. Palosuo, M. Jauhiainen, J. Sundvall, M. Vesanen, K. Mattila, and S. Asikainen. 2004. Severe periodontitis enhances macrophage activation via increased serum lipopolysaccharide. Arterioscler. Thromb. Vasc. Biol. 24: 2174-2180.
22. Loos, B. G., J. Craandijk, F. J. Hoek, P. M. Wertheim-van Dillen, and U. van der Velden. 2000. Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J. Periodontol. 71: 1528-1534.
23. Noack, B., R. J. Genco, M. Trevisan, S. Grossi, J. J. Zambon, and E. De Nardin. 2001. Periodontal infections contribute to elevated systemic C-reactive protein level. J. Periodontol. 72: 1221-1227.
24. D'Aiuto, F., D. Ready, and M. S. Tonetti. 2004. Periodontal disease and C-reactive protein-associated cardiovascular risk. J. Periodontal Res. 39: 236-241.
25. Pussinen, P. J., G. Alfthan, J. Tuomilehto, S. Asikainen, and P. Jousilahti. 2004. High serum antibody levels to Porphyromonas gingivalis predict myocardial infarction. Eur. J. Cardiovasc. Prev. Rehabil. 11: 408-411.
26. Lalla, E., I. B. Lamster, M. A. Hofmann, L. Bucciarelli, A. P. Jerud, S. Tucker, Y. Lu, P. N. Papapanou, and A. M. Schmidt. 2003. Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler. Thromb. Vasc. Biol. 23: 1405-1411.
27. Noack, B., I. Jachmann, S. Roscher, L. Sieber, S. Kopprasch, C. Luck, M. Hanefeld, and T. Hoffmann. 2000. Metabolic diseases and their possible link to risk indicators of periodontitis. J. Periodontol. 71: 898-903.
28. Cutler, C. W., E. A. Shinedling, M. Nunn, R. Jotwani, B. O. Kim, S. Nares, and A. M. Iacopino. 1999. Association between periodontitis and hyperlipidemia: cause or effect? J. Periodontol. 70: 1429-1434.
29. Cutler, C. W., R. L. Machen, R. Jotwani, and A. M. Iacopino. 1999. Heightened gingival inflammation and attachment loss in type 2 diabetics with hyperlipidemia. J. Periodontol. 70: 1313-1321.
30. Iacopino, A. M., and C. W. Cutler. 2000. Pathophysiological relationships between periodontitis and systemic disease: recent concepts involving serum lipids. J. Periodontol. 71: 1375-1384.
31. Cutler, C. W., and A. M. Iacopino. 2003. Periodontal disease: links with serum lipid/triglyceride levels? Review and new data. J. Int. Acad. Periodontol. 5: 47-51.
32. Berneis, K. K., and R. M. Krauss. 2002. Metabolic origins and clinical significance of LDL heterogeneity. J. Lipid Res. 43: 1363-1379.
33. Lada, A. T., and L. L. Rudel. 2004. Associations of low density lipoprotein particle composition with atherogenicity. Curr. Opin. Lipidol. 15: 19-24.
34. Campos, H., K. S. Arnold, M. E. Balestra, T. L. Innerarity, and R. M. Krauss. 1996. Differences in receptor binding of LDL subfractions. Arterioscler. Thromb. Vasc. Biol. 16: 794-801.
35. de Graaf, J., J. C. Hendriks, D. W. Swinkels, P. N. Demacker, and A. F. Stalenhoef. 1993. Differences in LDL receptor-mediated metabolism of three low density lipoprotein subfractions by human monocyte-derived macrophages: impact on the risk for atherosclerosis. Artery. 20: 201-230.
36. Galeano, N. F., R. Milne, Y. L. Marcel, M. T. Walsh, E. Levy, T. D. Ngu'yen, A. Gleeson, Y. Arad, L. Witte, M. al-Haideri, et al. 1994. Apoprotein B structure and receptor recognition of triglyceriderich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size. J. Biol. Chem. 269: 511-519.
37. Nigon, F., P. Lesnik, M. Rouis, and M. J. Chapman. 1991. Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. J. Lipid Res. 32: 1741-1753.
38. Hurt-Camejo, E., G. Camejo, B. Rosengren, F. Lopez, O. Wiklund, and G. Bondjers. 1990. Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages. J. Lipid Res. 31: 1387-1398.
39. Tribble, D. L., L. G. Holl, P. D. Wood, and R. M. Krauss. 1992. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis. 93: 189-199.
40. Chait, A., R. L. Brazg, D. L. Tribble, and R. M. Krauss. 1993. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am. J. Med. 94: 350-356.
41. Dejager, S., E. Bruckert, and M. J. Chapman. 1993. Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia. J. Lipid Res. 34: 295-308.
42. de Graaf, J., H. L. Hak-Lemmers, M. P. Hectors, P. N. Demacker, J. C. Hendriks, and A. F. Stalenhoef. 1991. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler. Thromb. 11: 298-306.
43. Tribble, D. L., M. Rizzo, A. Chait, D. M. Lewis, P. J. Blanche, and R. M. Krauss. 2001. Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense lowdensity lipoproteins. Am. J. Med. 110: 103-110.
44. Tribble, D. L., J. J. van den Berg, P. A. Motchnik, B. N. Ames, D. M. Lewis, A. Chait, and R. M. Krauss. 1994. Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and alpha-tocopherol content. Proc. Natl. Acad. Sci. USA. 91: 1183-1187.
45. Austin, M. A., J. L. Breslow, C. H. Hennekens, J. E. Buring, W. C. Willett, and R. M. Krauss. 1988. Low-density lipoprotein subclass patterns and risk of myocardial infarction. J. Am. Med. Assoc. 260: 1917-1921.
46. Gardner, C. D., S. P. Fortmann, and R. M. Krauss. 1996. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. J. Am. Med. Assoc. 276: 875-881.
47. Lamarche, B., I. Lemieux, and J. P. Despres. 1999. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects. Diabetes Metab. 25: 199-211.
48. Tselepis, A. D., and M. J. Chapman. 2002. Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase. Atheroscler. Suppl. 3: 57-68.
49. Karasawa, K., A. Harada, N. Satoh, K. Inoue, and M. Setaka. 2003. Plasma platelet activating factor-acetylhydrolase (PAF-AH). Prog. Lipid Res. 42: 93-114.
50. Hiramoto, M., H. Yoshida, T. Imaizumi, N. Yoshimizu, and K. Satoh. 1997. A mutation in plasma platelet-activating factor acetylhydrolase (Val279→Phe) is a genetic risk factor for stroke. Stroke. 28: 2417-2420.
51. Yamada, Y., S. Ichihara, T. Fujimura, and M. Yokota. 1998. Identification of the G994→T missense in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese men. Metabolism. 47: 177-181.
52. Arakawa, H., J. Y. Qian, D. Baatar, K. Karasawa, Y. Asada, Y. Sasaguri, E. R. Miller, J. L. Witztum, and H. Ueno. 2005. Local expression of platelet-activating factor-acetylhydrolase reduces accumulation of oxidized lipoproteins and inhibits inflammation, shear stress-induced thrombosis, and neointima formation in balloon-injured carotid arteries in nonhyperlipidemic rabbits. Circulation. 111: 3302-3309.
53. Al-Darmaki, S., H. A. Schenkein, J. G. Tew, and S. E. Barbour. 2003. Differential expression of platelet-activating factor acetylhydrolase in macrophages and monocyte-derived dendritic cells. J. Immunol. 170: 167-173.
54. Otvos, J. D. 1997. Handbook of Lipoprotein Testing. American Association for Clinical Chemistry Press, Washington, DC. 497-508.
55. Otvos, J. D. 2002. Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. Clin. Lab. 48: 171-180.
56. Schumaker, V. N., and D. L. Puppione. 1986. Sequential flotation ultracentrifugation. Methods Enzymol. 128: 155-170.
57. Peterson, G. L. 1983. Determination of total protein. Methods Enzymol. 91: 95-119.
58. Miwa, M., T. Miyake, T. Yamanaka, J. Sugatani, Y. Suzuki, S. Sakata, Y. Araki, and M. Matsumoto. 1988. Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J. Clin. Invest. 82: 1983-1991.
59. Narahara, H., I. Miyakawa, and J. M. Johnston. 1995. The inhibitory effect of 1,25-dihydroxyvitamin D3 on the secretion of platelet-activating factor acetylhydrolase by human decidual macrophages. J. Clin. Endocrinol. Metab. 80: 3121-3126.
60. McCall, M. R., M. La Belle, T. M. Forte, R. M. Krauss, Y. Takanami, and D. L. Tribble. 1999. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility. Biochim. Biophys. Acta. 1437: 23-36.
61. Shoji, T., Y. Nishizawa, T. Kawagishi, K. Kawasaki, H. Taniwaki, T. Tabata, T. Inoue, and H. Morii. 1998. Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients. J. Am. Soc. Nephrol. 9: 1277-1284.
62. Krauss, R. M. 1998. Atherogenicity of triglyceride-rich lipoproteins. Am. J. Cardiol. 81: 13B-17B.
63. Krauss, R. M. 1998. Triglycerides and atherogenic lipoproteins: rationale for lipid management. Am. J. Med. 105 (Suppl.): 58-62.
64. Packard, C. J. 2003. Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Biochem. Soc. Trans. 31: 1066-1069.
65. Cromwell, W. C., and J. D. Otvos. 2004. Low-density lipoprotein particle number and risk for cardiovascular disease. Curr. Atheroscler. Rep. 6: 381-387.
66. Schenkein, H. A., J. C. Gunsolley, A. M. Best, M. T. Harrison, C. L. Hahn, J. Wu, and J. G. Tew. 1999. Antiphosphorylcholine antibody levels are elevated in humans with periodontal diseases. Infect. Immun. 67: 4814-4818.
67. Schenkein, H. A., C. R. Berry, D. Purkall, J. A. Burmeister, C. N. Brooks, and J. G. Tew. 2001. Phosphorylcholine-dependent cross-reactivity between dental plaque bacteria and oxidized low-density lipoproteins. Infect. Immun. 69: 6612-6617.
68. Schenkein, H. A., C. R. Berry, J. A. Burmeister, C. N. Brooks, S. E. Barbour, A. M. Best, and J. G. Tew. 2003. Anti-cardiolipin antibodies in sera from patients with periodontitis. J. Dent. Res. 82: 919-922.
69. Schenkein, H. A., C. R. Berry, J. A. Burmeister, C. N. Brooks, A. M. Best, and J. G. Tew. 2004. Locally produced anti-phosphorylcholine and anti-oxidized low-density lipoprotein antibodies in gingival crevicular fluid from aggressive periodontitis patients. J. Periodontol. 75: 146-153.
70. Elstad, M. R., D. M. Stafforini, T. M. McIntyre, S. M. Prescott, and G. A. Zimmerman. 1989. Platelet-activating factor acetylhydrolase increases during macrophage differentiation. A novel mechanism that regulates accumulation of platelet-activating factor. J. Biol. Chem. 264: 8467-8470.